Showing results (111-120 of 284) with videos related to

Sort By:
Pageof 29
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 4, 2014
A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5Geoffrey A Block, Steven Fishbane, Mariano Rodriguez, et al.
Transplantation|July 16, 2015
A Prospective Cohort Study of Mineral Metabolism After Kidney TransplantationMyles Wolf, Matthew R Weir, Nelson Kopyt, et al.
Kidney International Reports|May 5, 2018
Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric OxideMasaaki Nakayama, Yoshihiro Tani, Wan-Jun Zhu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 6, 2012
Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT studyMarkus Ketteler, Kevin J Martin, Myles Wolf, et al.
Plos One|October 28, 2011
Hydroxyfasudil-mediated inhibition of ROCK1 and ROCK2 improves kidney function in rat renal acute ischemia-reperfusion injuryDominik Kentrup, Stefan Reuter, Uta Schnöckel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic ratsMaren Leifheit-Nestler, Alexander Grabner, Laura Hermann, et al.
Archives of Internal Medicine|June 15, 2007
Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination SurveyDavid Martins, Myles Wolf, Deyu Pan, et al.
Clinical Chemistry|June 10, 2008
N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurementsOrlando M Gutiérrez, Hector Tamez, Ishir Bhan, et al.
The Journal of Clinical Endocrinology and Metabolism|December 8, 2009
Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically activeTakashi Shimada, Itaru Urakawa, Tamara Isakova, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 6, 2020
Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance HemodialysisDaniel L Edmonston, Tamara Isakova, Laura M Dember, et al.
Pageof 29